{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T21:40:24Z","timestamp":1785015624027,"version":"3.55.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1001\/jamaophthalmol.2018.2198","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T16:21:00Z","timestamp":1528993260000},"page":"920","source":"Crossref","is-referenced-by-count":54,"title":["Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease"],"prefix":"10.1001","volume":"136","author":[{"given":"Xiangrong","family":"Kong","sequence":"first","affiliation":[{"name":"School of Public Health and Health Sciences, University of Massachusetts-Amherst, Amherst"},{"name":"Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"},{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Fujinami","sequence":"additional","affiliation":[{"name":"Laboratory of Visual Physiology, Division for Vision Research, National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan"},{"name":"Department of Ophthalmology, Keio University, School of Medicine, Tokyo, Japan"},{"name":"Moorfields Eye Hospital, London, United Kingdom"},{"name":"UCL Institute of Ophthalmology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert W.","family":"Strauss","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, London, United Kingdom"},{"name":"UCL Institute of Ophthalmology, University College London, London, United Kingdom"},{"name":"Department of Ophthalmology, Johannes Kepler University (Clinic) Linz, Linz, Austria"},{"name":"Department of Ophthalmology, Medical University Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Munoz","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"West","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur V.","family":"Cideciyan","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Michaelides","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital, London, United Kingdom"},{"name":"UCL Institute of Ophthalmology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Margret","family":"Ervin","sequence":"additional","affiliation":[{"name":"Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"},{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Sch\u00f6nbach","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet K.","family":"Cheetham","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Clinical Research Institute, Columbia, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik P. N.","family":"Scholl","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Ophthalmology, University of Basel, Basel, Switzerland"},{"name":"Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ProgStar Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"eoi180045r1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/jmg.40.9.641","article-title":"The genetics of inherited macular dystrophies.","volume":"40","author":"Michaelides","year":"2003","journal-title":"J Med Genet"},{"issue":"3","key":"eoi180045r2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ng0397-236","article-title":"A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy.","volume":"15","author":"Allikmets","year":"1997","journal-title":"Nat Genet"},{"issue":"1","key":"eoi180045r3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/bjophthalmol-2016-308823","article-title":"Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options.","volume":"101","author":"Tanna","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"eoi180045r4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.oret.2017.02.008","article-title":"Progression of visual acuity and fundus autofluorescence in recent-onset stargardt disease: ProgStar study report #4.","volume":"1","author":"Kong","year":"2017","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"eoi180045r5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.ophtha.2016.05.027","article-title":"Visual acuity loss and associated risk factors in the retrospective progression of stargardt disease study (ProgStar report no. 2).","volume":"123","author":"Kong","year":"2016","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi180045r6","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.ophtha.2017.04.026","article-title":"Visual acuity change over 12 months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) study: ProgStar report number 6.","volume":"124","author":"Kong","year":"2017","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi180045r7","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.ophtha.2006.04.027","article-title":"Comparison of visual acuity loss in patients with different stages of Stargardt\u2019s disease.","volume":"113","author":"Kim","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi180045r8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0161-6420(03)00333-6","article-title":"Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.","volume":"110","author":"Rotenstreich","year":"2003","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi180045r9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/13816810802695550","article-title":"Natural history of phenotypic changes in Stargardt macular dystrophy.","volume":"30","author":"Walia","year":"2009","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"eoi180045r10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/hum.2015.147","article-title":"Let there be light: gene and cell therapy for blindness.","volume":"27","author":"Dalkara","year":"2016","journal-title":"Hum Gene Ther"},{"issue":"9967","key":"eoi180045r11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: follow-up of two open-label phase 1\/2 studies.","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"eoi180045r12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1167\/iovs.14-16049","article-title":"Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium.","volume":"56","author":"Thompson","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"368","key":"eoi180045r13","doi-asserted-by":"publisher","first-page":"368rv6","DOI":"10.1126\/scitranslmed.aaf2838","article-title":"Emerging therapies for inherited retinal degeneration.","volume":"8","author":"Scholl","year":"2016","journal-title":"Sci Transl Med"},{"issue":"4","key":"eoi180045r14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ophtha.2015.12.009","article-title":"The natural history of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) studies: design and baseline characteristics: ProgStar report no. 1.","volume":"123","author":"Strauss","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi180045r15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0161-6420(13)38009-9","article-title":"Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"eoi180045r16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ajo.2016.06.003","article-title":"Comparison of short-wavelength reduced-illuminance and conventional autofluorescence imaging in stargardt macular dystrophy.","volume":"168","author":"Strauss","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"eoi180045r17","doi-asserted-by":"publisher","first-page":"BIO61","DOI":"10.1167\/iovs.16-21210","article-title":"Combined fundus autofluorescence and near infrared reflectance as prognostic biomarkers for visual acuity in foveal-sparing geographic atrophy.","volume":"58","author":"Lindner","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"eoi180045r18","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1167\/iovs.13-12104","article-title":"A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.","volume":"54","author":"Fujinami","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi180045r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0006-341X.2002.00001.x","article-title":"Model-checking techniques based on cumulative residuals.","volume":"58","author":"Lin","year":"2002","journal-title":"Biometrics"},{"issue":"2","key":"eoi180045r21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajo.2004.09.039","article-title":"Objective analysis of retinal damage in HIV-positive patients in the HAART era using OCT.","volume":"139","author":"Kozak","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi180045r22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF00153630","article-title":"Main types of bull\u2019s eye maculopathy: functional classification.","volume":"58","author":"Pinckers","year":"1984","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"eoi180045r23","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1167\/iovs.06-0764","article-title":"Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.","volume":"48","author":"Aleman","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi180045r24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ophtha.2014.08.012","article-title":"Clinical and molecular characteristics of childhood-onset Stargardt disease.","volume":"122","author":"Fujinami","year":"2015","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi180045r25","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.1167\/iovs.13-13825","article-title":"Foveal sparing in Stargardt disease.","volume":"55","author":"van Huet","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi180045r26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s10384-012-0172-1","article-title":"Foveal sparing in patients with Japanese Stargardt\u2019s disease and good visual acuity.","volume":"56","author":"Nakao","year":"2012","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"eoi180045r27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajo.2013.05.003","article-title":"Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function.","volume":"156","author":"Fujinami","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi180045r28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.exer.2010.03.021","article-title":"Analysis of autofluorescent retinal images and measurement of atrophic lesion growth in Stargardt disease.","volume":"91","author":"Chen","year":"2010","journal-title":"Exp Eye Res"},{"issue":"7","key":"eoi180045r29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3109\/02713681003707235","article-title":"Paradoxical improvement of visual acuity in macular disease.","volume":"35","author":"Ishiko","year":"2010","journal-title":"Curr Eye Res"},{"issue":"3","key":"eoi180045r30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00006982-198500530-00001","article-title":"Spontaneous visual improvement in the first affected eye of patients with bilateral disciform scars.","volume":"5","author":"Singerman","year":"1985","journal-title":"Retina"},{"issue":"3","key":"eoi180045r31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamaophthalmol.2014.21","article-title":"Spontaneous improvement in visual acuity in age-related geographic atrophy of the macula.","volume":"132","author":"Sunness","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"eoi180045r32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/00006982-200002000-00009","article-title":"Improvement of visual acuity over time in patients with bilateral geographic atrophy from age-related macular degeneration.","volume":"20","author":"Sunness","year":"2000","journal-title":"Retina"},{"issue":"1","key":"eoi180045r33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.oret.2016.08.009","article-title":"Fixation location and stability using the MP-1 microperimeter in Stargardt disease: ProgStar report no. 3.","volume":"1","author":"Sch\u00f6nbach","year":"2016","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"eoi180045r34","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.1167\/iovs.05-0805","article-title":"ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina.","volume":"46","author":"Cideciyan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi180045r35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/humu.2017.38.issue-4","article-title":"In silico functional meta-analysis of 5,962 ABCA4 variants in 3,928 retinal dystrophy cases.","volume":"38","author":"Cornelis","year":"2017","journal-title":"Hum Mutat"},{"issue":"5","key":"eoi180045r37","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1167\/iovs.14-16343","article-title":"Quantitative fundus autofluorescence and optical coherence tomography in PRPH2\/RDS- and ABCA4-associated disease exhibiting phenotypic overlap.","volume":"56","author":"Duncker","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"eoi180045r38","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1136\/bjo.82.12.1372","article-title":"Difficulty in performing everyday activities in patients with juvenile macular dystrophies: comparison with patients with retinitis pigmentosa.","volume":"82","author":"Szlyk","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"eoi180045r39","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","article-title":"Visual acuity as an outcome measure in clinical trials of retinal diseases.","volume":"114","author":"Beck","year":"2007","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi180045r40","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamaophthalmol.2017.4152","article-title":"Progression of Stargardt disease as determined by fundus autofluorescence in the retrospective progression of Stargardt Disease Study (ProgStar report no. 9).","volume":"135","author":"Strauss","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"eoi180045r19","doi-asserted-by":"publisher","DOI":"10.1142\/p742","volume-title":"The Epidemiology of Eye Disease","author":"Johnson","year":"2012","edition":"3rd ed"},{"key":"eoi180045r36","unstructured":"OMIM Entry #248200: Stargardt Disease 1; STGD1. https:\/\/www.omim.org\/entry\/248200. Accessed May 8, 2018."}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2684573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T15:22:59Z","timestamp":1533828179000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.2198"}},"subtitle":["ProgStar Study Report No. 10"],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.2198","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}